News
CNVVF
3.150
NaN%
--
Convatec Non-Executive Director Jens Viebke Increases Stake with Share Purchase
TipRanks · 10/14 10:02
Convatec Advances $200m Share Buyback, Updates Voting Rights
TipRanks · 10/12 10:03
Convatec Survey Challenges Assumptions About Leakage in Ostomy Care
Barchart · 10/06 02:00
Convatec Adds to Treasury Stock with Latest Tranche in $200m Buyback
TipRanks · 10/05 10:02
Convatec Updates Market on Total Voting Rights and Share Buyback Activity
TipRanks · 10/01 10:07
Barclays Reaffirms Their Buy Rating on ConvaTec (CTEC)
TipRanks · 10/01 09:15
Convatec Increases Treasury Stock with Latest Tranche of $200m Buyback
TipRanks · 09/28 10:03
Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize
Barchart · 09/28 06:00
Convatec Adds to $200m Buyback, Updates Voting Rights
TipRanks · 09/21 10:02
Convatec Advances $200m Share Buyback, Tightens Free Float
TipRanks · 09/14 10:02
Berenberg Bank Remains a Buy on ConvaTec (CTEC)
TipRanks · 09/11 09:06
Convatec Advances $200m Buyback, Updates Share Capital and Voting Rights
TipRanks · 09/07 10:03
ConvaTec (CTEC) Gets a Buy from Morgan Stanley
TipRanks · 09/02 07:16
Convatec Updates Total Voting Rights Amid Ongoing Share Buyback
TipRanks · 09/01 10:07
Convatec Advances $200m Buyback, Lifts Treasury Share Holdings
TipRanks · 09/01 10:05
Coloplast: Great Business, Fair Price, Bad Timing
Seeking Alpha · 08/28 07:06
Convatec strengthens board with medtech veteran Jens Viebke
TipRanks · 08/27 06:09
Convatec Updates Market on Progress of $200m Share Buyback Programme
TipRanks · 08/24 10:02
Convatec’s $200m Buyback Pushes Treasury Shares Above FCA Threshold
TipRanks · 08/21 10:02
Convatec Advances $200m Buyback with New Treasury Share Purchases
TipRanks · 08/10 06:12
More
Webull provides a variety of real-time CNVVF stock news. You can receive the latest news about Convatec Group Plc through multiple platforms. This information may help you make smarter investment decisions.
About CNVVF
Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It provides a range of benefits, from infection prevention and protection of at-risk skin to improved patient outcomes. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes.